The present study sought to investigate the effect of integrin β3 on AXL expression and the mechanism by which integrin β3 regulates AXL expression and promotes resistance to EGFR-TKI in NSCLC cells. This evidence concerns the gene EGFR and non-small cell lung carcinoma.